Systemic iodine 125 activity after GliaSite brachytherapy: Safety considerations

Brachytherapy

Volumn 7, Issue 1, 2008, Pages 43-46

  Adkison, Jarrod B ^a   Thomadsen, Bruce ^a   Howard, Steven P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Brachytherapy; Contamination; GliaSite; Incontinence; Iotrex

Indexed keywords

IODINE 125; IOTREX; UNCLASSIFIED DRUG;

ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTAMINATION; CONTROLLED STUDY; DRUG ABSORPTION; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SAFETY; URINARY EXCRETION; URINE INCONTINENCE;

BRACHYTHERAPY; BRAIN NEOPLASMS; CATHETERS, INDWELLING; EQUIPMENT CONTAMINATION; EQUIPMENT FAILURE; FEMALE; HUMANS; IODINE RADIOISOTOPES; RADIATION PROTECTION; RETROSPECTIVE STUDIES; URINALYSIS; URINARY INCONTINENCE;

EID: 39549119131     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2007.11.001     Document Type: Article

References (10)

1. Chan T.A., Weingart J.D., Parisi M., et al. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1133-1139
2. Brem H., Piantadosi S., Burger P.C., et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345 (1995) 1008-1012
3. Rogers L.R., Rock J.P., Sills A.K., et al. Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg 105 (2006) 375-384
4. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial. JAMA 280 (1998) 1485-1489
5. Stubbs J.B., Strickland A.D., Frank R.K., et al. Biodistribution and dosimetry of an aqueous solution containing sodium 3-(125I)iodo-4-hydroxybenzenesulfonate (Iotrex) for brachytherapy of resected malignant brain tumors. Cancer Biother Radiopharm 15 (2000) 645-656
6. deGuzman A.F., Kearns W.T., Shaw E., et al. Radiation safety issues with high activities of liquid I-125: Techniques and experience. J Appl Clin Med Phys 4 (2003) 143-148
7. Strzelczyk J., and Safadi R. Radiation safety considerations in GliaSite 125I brain implant procedures. Health Phys 86 (2004) S120-S123
8. Tatter S.B., Shaw E.G., Rosenblum M.L., et al. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: Multicenter safety and feasibility trial. J Neurosurg 99 (2003) 297-303
9. Noble J.M., Canoll P., and Honig L.S. Brain tumor-associated dementia. Sci Aging Knowledge Environ 2005 (2005) dn2
10. Duffau H., and Capelle L. Incontinence after brain glioma surgery: New insights into the cortical control of micturition and continence. Case report. J Neurosurg 102 (2005) 148-151